200 related articles for article (PubMed ID: 36191643)
1. Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program.
Epperson CN; Rubinow DR; Meltzer-Brody S; Deligiannidis KM; Riesenberg R; Krystal AD; Bankole K; Huang MY; Li H; Brown C; Kanes SJ; Lasser R
J Affect Disord; 2023 Jan; 320():353-359. PubMed ID: 36191643
[TBL] [Abstract][Full Text] [Related]
2. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
Meltzer-Brody S; Colquhoun H; Riesenberg R; Epperson CN; Deligiannidis KM; Rubinow DR; Li H; Sankoh AJ; Clemson C; Schacterle A; Jonas J; Kanes S
Lancet; 2018 Sep; 392(10152):1058-1070. PubMed ID: 30177236
[TBL] [Abstract][Full Text] [Related]
3. Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression.
Deligiannidis KM; Citrome L; Huang MY; Acaster S; Fridman M; Bonthapally V; Lasser R; Kanes SJ
J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36724109
[No Abstract] [Full Text] [Related]
4. Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
Deligiannidis KM; Meltzer-Brody S; Gunduz-Bruce H; Doherty J; Jonas J; Li S; Sankoh AJ; Silber C; Campbell AD; Werneburg B; Kanes SJ; Lasser R
JAMA Psychiatry; 2021 Sep; 78(9):951-959. PubMed ID: 34190962
[TBL] [Abstract][Full Text] [Related]
5. Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression.
Cooper MC; Kilvert HS; Hodgkins P; Roskell NS; Eldar-Lissai A
CNS Drugs; 2019 Oct; 33(10):1039-1052. PubMed ID: 31642037
[TBL] [Abstract][Full Text] [Related]
6. Brexanolone in Postpartum Depression:
Gerbasi ME; Meltzer-Brody S; Acaster S; Fridman M; Bonthapally V; Hodgkins P; Kanes SJ; Eldar-Lissai A
J Womens Health (Larchmt); 2021 Mar; 30(3):385-392. PubMed ID: 33181049
[No Abstract] [Full Text] [Related]
7. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
[TBL] [Abstract][Full Text] [Related]
8. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
Kanes SJ; Colquhoun H; Doherty J; Raines S; Hoffmann E; Rubinow DR; Meltzer-Brody S
Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370307
[TBL] [Abstract][Full Text] [Related]
9. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
[TBL] [Abstract][Full Text] [Related]
10. Brexanolone for postpartum depression.
Hutcherson TC; Cieri-Hutcherson NE; Gosciak MF
Am J Health Syst Pharm; 2020 Feb; 77(5):336-345. PubMed ID: 32073124
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials.
Dunner DL; Lipschitz A; Pitts CD; Davies JT
Clin Ther; 2005 Dec; 27(12):1901-11. PubMed ID: 16507376
[TBL] [Abstract][Full Text] [Related]
12. Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies.
Zheng W; Cai DB; Zheng W; Sim K; Ungvari GS; Peng XJ; Ning YP; Wang G; Xiang YT
Psychiatry Res; 2019 Sep; 279():83-89. PubMed ID: 31323375
[TBL] [Abstract][Full Text] [Related]
13. Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
Leader LD; O'Connell M; VandenBerg A
Pharmacotherapy; 2019 Nov; 39(11):1105-1112. PubMed ID: 31514247
[TBL] [Abstract][Full Text] [Related]
14. Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.
Gerbasi ME; Eldar-Lissai A; Acaster S; Fridman M; Bonthapally V; Hodgkins P; Kanes SJ; Meltzer-Brody S
Arch Womens Ment Health; 2020 Oct; 23(5):727-735. PubMed ID: 32666402
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
17. Achieving clinical response in postpartum depression leads to improvement in health-related quality of life.
Gerbasi ME; Kosinski M; Meltzer-Brody S; Acaster S; Fridman M; Huang MY; Bonthapally V; Hodgkins P; Kanes SJ; Eldar-Lissai A
Curr Med Res Opin; 2021 Jul; 37(7):1221-1231. PubMed ID: 33719782
[TBL] [Abstract][Full Text] [Related]
18. The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
Farabaugh A; Mischoulon D; Fava M; Wu SL; Mascarini A; Tossani E; Alpert JE
Int Clin Psychopharmacol; 2005 Mar; 20(2):87-91. PubMed ID: 15729083
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of some new GABAkines for treatment of depression: A systematic review and meta-analysis from randomized controlled trials.
Zou J; Yang L; Yang G; Gao J
Psychiatry Res; 2023 Oct; 328():115450. PubMed ID: 37683318
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
Bauer M; McIntyre RS; Szamosi J; Eriksson H
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
